Shareholders Win Cert. In Suit Over Matrixx Cold Medicine

Law360, New York (February 27, 2012, 4:41 PM ET) -- A group of shareholders won class certification Monday in an 8-year-old Arizona suit alleging Matrixx Initiatives Inc. violated securities laws by concealing reports that cold medication Zicam caused a potentially permanent loss of the sense of smell.

U.S. District Judge Neil V. Wake certified a class of all people and entities who were damaged by their purchases of publicly traded Matrixx securities between Oct. 22, 2003, and Feb. 6, 2004, in a case that traveled all the way up to the U.S. Supreme Court before eventually...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers